Artificial Intelligence-Assisted vs Surgeon-Directed Screw Planning in Robotic Femoral Neck Fracture Surgery
Launched by WUHAN UNION HOSPITAL, CHINA · Apr 18, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different ways to plan the placement of screws during robotic surgery for femoral neck fractures, which are common injuries in the hip area. One method uses guidance from artificial intelligence (AI), while the other relies on the surgeon's experience. The main goal is to find out if using AI can make the surgery more accurate, reduce the time it takes, lower the amount of blood lost during the procedure, and lead to better recovery outcomes compared to the traditional method.
To participate in this trial, individuals need to be at least 18 years old and have a confirmed femoral neck fracture that requires surgery with robotic assistance. They should also be able to understand the study and agree to participate. Participants will receive standard care and follow-up after surgery, and their progress will be monitored for six months through assessments and imaging tests. It's important to note that individuals with certain health issues or who cannot undergo surgery may not be eligible. This study aims to see if AI can truly enhance the precision and safety of these surgeries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years;
- • Radiologically confirmed diagnosis of femoral neck fracture (displaced or non-displaced);
- • Scheduled to undergo robotic-assisted internal fixation with cannulated screws as the initial treatment strategy during the study period;
- • Capable of understanding the study procedures and providing informed consent;
- • Willing and able to adhere to the prescribed postoperative follow-up schedule and rehabilitation instructions.
- Exclusion Criteria:
- • Evidence of avascular necrosis of the femoral head on the affected side prior to surgery;
- • Inability to tolerate the surgical intervention;
- • Severe physical illnesses, cognitive problems (such as memory loss), or mental health conditions that may impair the ability to comply with medical instructions or attending scheduled follow-up appointments.
About Wuhan Union Hospital, China
Wuhan Union Hospital, affiliated with Huazhong University of Science and Technology, is a leading medical institution located in Wuhan, China. Renowned for its comprehensive healthcare services and advanced research capabilities, the hospital plays a pivotal role in clinical trials aimed at enhancing medical knowledge and patient care. With a commitment to innovation and excellence, Wuhan Union Hospital collaborates with various stakeholders to conduct rigorous and ethically sound clinical research, contributing significantly to the advancement of medical science and public health both domestically and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wuhan, Hubei, China
Patients applied
Trial Officials
Guohui Liu, MD, PhD
Principal Investigator
Wuhan Union Hospital, China
Bobin Mi, MD, PhD
Principal Investigator
Wuhan Union Hospital, China
Fawwaz O. Al-Smadi, MD
Principal Investigator
Wuhan Union Hospital, China
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported